Show simple item record

Authordc.contributor.authorRiquelme Neira, Roberto 
Authordc.contributor.authorRivera, Alejandra 
Authordc.contributor.authorSáez, Darwin 
Authordc.contributor.authorFernández, Pablo 
Authordc.contributor.authorOsorio Abarzúa, Carlos Gonzalo 
Authordc.contributor.authorCanto Fuentes, Felipe del 
Authordc.contributor.authorSalazar Garrido, Juan 
Authordc.contributor.authorVidal Álvarez, Roberto 
Authordc.contributor.authorOñate, Angel 
Admission datedc.date.accessioned2016-05-20T15:56:17Z
Available datedc.date.available2016-05-20T15:56:17Z
Publication datedc.date.issued2016
Cita de ítemdc.identifier.citationFrontiers in Cellular and Infection Microbiology, 20 January 2016, Volume 5, Article 104en_US
Identifierdc.identifier.otherDOI: 10.3389/fcmib.2015.00104
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/138399
General notedc.descriptionArtículo de publicación ISIen_US
Abstractdc.description.abstractEnterohemorrhagic Escherichia coil (EHEC) O157:H7 is the predominant causative agent of hemorrhagic colitis in humans and is the cause of haemolytic uraemic syndrome and other illnesses. Cattle have been implicated as the main reservoir of this organism. Here, we evaluated the immunogenicity and protective efficacy of a DNA vaccine encoding conserved sequences of truncated EHEC factor for adherence-1 (efa-1') in a mouse model. Intranasal administration of plasmid DNA carrying the efa-1' gene (pVAXefa-1') into C57BL/6 mice elicited both humoral and cellular immune responses. In animals immunized with pVAXefa-1', EHEC-secreted protein specific IgM and IgG antibodies were detected in sera at day 45. Anti-EHEC-secreted protein sIgA was also detected in nasal and bronchoalveolar lavages. In addition, antigen-specific T-cell-proliferation, IL-10, and IFN-gamma were observed upon re-stimulation with either heat-killed bacteria or EHEC-secreted proteins. Vaccinated animals were also protected against challenge with E. coli O157:H7 strain EDL933. These results suggest that DNA vaccine encoding efa-1' have therapeutic potential in interventions against EHEC infections. This approach could lead to a new strategy in the production of vaccines that prevent infections in cattle.en_US
Patrocinadordc.description.sponsorshipFondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT), Santiago, Chile 1110260 1130093en_US
Lenguagedc.language.isoenen_US
Publisherdc.publisherFrontiers Media S.A.en_US
Type of licensedc.rightsAtribución-NoComercial-SinDerivadas 3.0 Chile*
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/*
Keywordsdc.subjectDNA vaccineen_US
Keywordsdc.subjectTruncated efa-1 geneen_US
Keywordsdc.subjectEnterohemorragic E. coilen_US
Keywordsdc.subjectO157:H7 serotypeen_US
Keywordsdc.subjectProtective to miceen_US
Títulodc.titleVaccination with DNA Encoding Truncated Enterohemorrhagic Escherichia coil (EHEC) Factor for Adherence-1 Gene (efa-1') Confers Protective Immunity to Mice Infected with E. coil O157:H7en_US
Document typedc.typeArtículo de revista


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Atribución-NoComercial-SinDerivadas 3.0 Chile
Except where otherwise noted, this item's license is described as Atribución-NoComercial-SinDerivadas 3.0 Chile